Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

09293

Sigma-Aldrich

2-(3-Aminopropylamino)ethanol

≥98.0% (GC)

Synonym(s):

N-(2-Hydroxyethyl)trimethylenediamine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
NH2CH2CH2CH2NHCH2CH2OH
CAS Number:
4461-39-6
Molecular Weight:
118.18
Beilstein:
1734412
EC Number:
224-718-0
MDL number:
MFCD00025617
UNSPSC Code:
12352100
PubChem Substance ID:
329748756
NACRES:
NA.22
Pricing and availability is not currently available.

Quality Level

100

Assay

≥98.0% (GC)

refractive index

n20/D 1.486

bp

250-252 °C (lit.)

density

1.007 g/mL at 20 °C (lit.)

SMILES string

NCCCNCCO

InChI

1S/C5H14N2O/c6-2-1-3-7-4-5-8/h7-8H,1-6H2

InChI key

GHKSKVKCKMGRDU-UHFFFAOYSA-N

Gene Information

rat ... Grin2a(24409)

Other Notes

Inhibitor of the mammalian glycogen debranching enzyme[1]; Photographic development accelerator.

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H314,H317

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - Skin Sens. 1

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 3

Flash Point(F)

296.6 °F

Flash Point(C)

147 °C

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme.
B K Gillard et al.
Biochemistry, 16(18), 3978-3987 (1977-09-06)
Panagiotis Mastorakos et al.
Journal of controlled release : official journal of the Controlled Release Society, 262, 37-46 (2017-07-12)
The discovery of powerful genetic targets has spurred clinical development of gene therapy approaches to treat patients with malignant brain tumors. However, lack of success in the clinic has been attributed to the inability of conventional gene vectors to achieve
Stephany Y Tzeng et al.
International journal of nanomedicine, 6, 3309-3322 (2012-01-10)
Biodegradable poly(ester amine) (PEA)-based and poly(amido amine) (PAA)-based nanoparticles were developed for efficient in vitro siRNA delivery to human umbilical vein endothelial cells (HUVECs). They were screened, characterized, and compared with traditionally studied DNA-containing particles. Several of the polymeric nanoparticles
Camila G Zamboni et al.
Journal of controlled release : official journal of the Controlled Release Society, 263, 18-28 (2017-03-30)
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the US, with a meager 5-year survival rate of <20%. Such unfavorable numbers are closely related to the heterogeneity of the disease and the unsatisfactory therapies currently used to manage
Antonella Mangraviti et al.
ACS nano, 9(2), 1236-1249 (2015-02-03)
Biodegradable polymeric nanoparticles have the potential to be safer alternatives to viruses for gene delivery; however, their use has been limited by poor efficacy in vivo. In this work, we synthesize and characterize polymeric gene delivery nanoparticles and evaluate their

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service